CGG is led by Sandeep Dave, MD, MS, and Simon Gregory, PhD. Dr. Dave is a physician-scientist and clinical oncologist. He is an Associate Professor of Medicine at the Center for Genomic and Computational Biology at Duke University. He completed medical school and graduate school at Northwestern University, and a clinical and post-doctoral fellowship at the National Institutes of Health. He is the PI of several peer-reviewed grants including two R01 grants and an R21 grant from the NCI as well those from other agencies including the Leukemia Lymphoma Society and the Department of Defense. His work has applied high throughput sequencing to unravel the genetic causes of lymphoma (e.g. Love et al, Nature Genetics 2012) and for understanding the molecular underpinnings of response to targeted therapies (e.g. Walsh et al, Clin Canc Research 2013). Dr. Dave also leads the international Hematologic Malignancies Research Consortium, an international group of collaborating institutions that is focused on applying genomics to better define these cancers. The consortium includes several NCI-designated Comprehensive Cancer Centers.
Dr. Gregory is an Associate Director at the Duke Molecular Physiology Institute (DMPI), and leader of the DMPI’s Section of Genomics and Epigenetics. Dr. Gregory completed his graduate education at the Wellcome Trust Sanger Institute before joining Duke University Medical Center in 2003. His research involves using next-generation sequence based techniques (exome-, methyl- and RNA-sequencing) and microarray based approaches to characterize the molecular profiles of solid tumors (brain and prostate cancer), circulating tumor cells (prostate cancer), and cell free DNA (lung cancer). Dr. Gregory was co-founder and former director of the Duke Epigenetics and Epigenomics Program, and is the Director of the Genomics Core Laboratory at the David H Murdock Research Institute.
Dr. Dave and Dr. Gregory organize the monthly program-wide meetings and host the external speakers for the monthly meeting and the yearly symposium.